All 11–12 year olds should be vaccinated with a quadrivalent (protects against serogroups A, C, W, and Y) meningococcal conjugate vaccine (Menactra® or Menveo®). A booster dose is recommended at age 16 years.For teens who receive the first dose at age 13 through 15 years, a booster dose should be administered, preferably at age 16 through 18 years, before the period of increased risk.he minimum interval between doses is 8 weeks. However, teens who receive their first dose of quadrivalent meningococcal conjugate vaccine at or after age 16 do not need a booster dose.